Company Bright Green Corporation

BGXX

US10920G1004

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
0.2638 ^USD	-1.82%		+0.46%	-20.08%

Jun. 10	Bright Green Insider Sold Shares Worth $359,700, According to a Recent SEC Filing	MT
May. 20	Bright Green Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Bright Green Corporation is a producer and manufacturer of plant-based drugs and active pharmaceutical ingredients (APIs). The Company specializes in the research, production, distribution, and advancement of plant-based drugs and APIs, including psilocybin, psilocyn, peyote, and opium poppy. It plans to focus on the development of cannabis strains and sales of cannabis and hemp products with high contents of cannabinol (CBN) and cannabigerol (CBG). It also plans to cultivate cannabis and focus on the production of dried flowers, and oils and marijuana extracts. In addition to cannabis, it also has a separate area for controlled substance cactus cultivation, and a separate controlled area for mushroom propagation. It is in the process of completing construction of the 22-acre existing greenhouse to comply with the requirements for Schedule I and Schedule II plant-based drugs. It also plans to construct two new 57-acre greenhouses, one each on the Candelaria property and Azuz property.

Number of employees: 5

Managers	Title	Age	Since
Saleem Elmasri DFI	Director of Finance/CFO	39	22-02-28
Gurvinder Singh		47	-

Members of the board	Title	Age	Since
Lynn Stockwell FOU	Founder	66	19-04-15
Dean Valore BRD	Director/Board Member	51	19-12-31
Robert Arnone BRD	Director/Board Member	57	21-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	190,166,318	70,644,700 ( 37.15 %)	0	37.15 %

Name	Equities	%	Valuation
Lynn Stockwell 35.85 %	68,183,658	35.85 %	17 M $
Terry Rafih 11.79 %	22,425,000	11.79 %	6 M $
Ernie Mailloux 11.15 %	21,200,000	11.15 %	5 M $
BlackRock Advisors LLC 1.816 %	3,453,910	1.816 %	873 839 $
Vanguard Fiduciary Trust Co. 1.489 %	2,831,636	1.489 %	716 404 $
Geode Capital Management LLC 0.7690 %	1,462,339	0.7690 %	369 972 $
ETF Managers Group LLC 0.7302 %	1,388,675	0.7302 %	351 335 $
Saleem Elmasri 0.6310 %	1,200,000	0.6310 %	303 600 $
STATE STREET CORPORATION 0.5273 %	1,002,748	0.5273 %	253 695 $
Gurvinder Singh 0.4601 %	875,000	0.4601 %	221 375 $

Bright Green Corp.

1033 George Hanosh Boulevard

87020, Grants

http://www.brightgreen.us

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
BRIGHT GREEN CORPORATION	-20.08%	50.17M
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
ROCHE HOLDING AG	+4.21%	230B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B